Showing results (1-10 of 65) with videos related to
Sort By:
Pageof 7
Cell Death and Differentiation|December 15, 2017
The interplay between mutant p53 and the mevalonate pathwayAlejandro Parrales, Elizabeth Thoenen, Tomoo IwakumaCancer Research|June 17, 2020
TAp63-miRNA-AURKA Axis as a Therapeutic Target for Cutaneous Squamous Cell CarcinomaAlejandro Parrales, Tomoo IwakumaFrontiers in Oncology|January 7, 2016
Targeting Oncogenic Mutant p53 for Cancer TherapyAlejandro Parrales, Tomoo IwakumaInternational Journal of Molecular Sciences|December 16, 2016
p53 as a Regulator of Lipid Metabolism in CancerAlejandro Parrales, Tomoo IwakumaNature Communications|March 11, 2025
Suppression of stress granule formation is a vulnerability imposed by mutant p53Elizabeth Thoenen, Atul Ranjan, Alejandro Parrales, et al.Pharmacology & Therapeutics|July 6, 2019
TP53 in bone and soft tissue sarcomasElizabeth Thoenen, Amanda Curl, Tomoo IwakumaCancers|April 14, 2026
MDM4 at the Crossroads: Beyond p53 and MDM2Dipesh Thapa, Allison St John, Alejandro Parrales, et al.Biorxiv : the Preprint Server for Biology|June 4, 2026
The combination of EWSR1-FLI1 and loss of one EWSR1 allele leads to the induction of trisomy 8Harsha Hapugaswatta, Alejandro Parrales, Hyewon Park, et al.Nature Cell Biology|October 28, 2016
DNAJA1 controls the fate of misfolded mutant p53 through the mevalonate pathwayAlejandro Parrales, Atul Ranjan, Swathi V Iyer, et al.Oncotarget|December 25, 2015
Allele-specific silencing of mutant p53 attenuates dominant-negative and gain-of-function activitiesSwathi V Iyer, Alejandro Parrales, Priya Begani, et al.Pageof 7